Search Results - "Schiff, Devora"
-
1
Ionizing Radiation Sensitizes Breast Cancer Cells to Bcl-2 Inhibitor, ABT-737, through Regulating Mcl-1
Published in Radiation research (01-12-2014)“…Breast-conserving surgery followed by radiation therapy has become the standard of care for early stage breast cancer. However, there are some patients that…”
Get full text
Journal Article -
2
Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation
Published in World journal of gastrointestinal oncology (15-03-2014)“…AIM:To investigate whether the inhibition of autophagy by chloroquine(CQ)sensitizes rectal tumors to radiation therapy(RT)or concurrent…”
Get full text
Journal Article -
3
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer
Published in Journal for immunotherapy of cancer (01-07-2023)“…BackgroundImmunotherapies are becoming front-line treatments for many advanced cancers, and combinations of two or more therapies are beginning to be…”
Get full text
Journal Article -
4
Is Ki-67 Expression Prognostic for Local Relapse in Early-Stage Breast Cancer Patients Treated With Breast Conservation Therapy (BCT)?
Published in International journal of radiation oncology, biology, physics (01-10-2013)“…Purpose Ki-67 is a human nuclear protein whose expression is strongly up-regulated in proliferating cells and can be used to determine the growth fraction in…”
Get full text
Journal Article -
5
Clinicopathologic Significance of Excision Repair Cross-Complementation 1 Expression in Patients Treated With Breast-Conserving Surgery and Radiation Therapy
Published in International journal of radiation oncology, biology, physics (01-03-2010)“…Purpose The excision repair cross-complementation 1 (ERCC1) enzyme plays a rate-limiting role in the nucleotide excision repair pathway and is associated with…”
Get full text
Journal Article -
6
Evaluation of Single Nucleotide Polymorphisms (SNPs) in the p53 Binding Protein 1 ( TP53BP1 ) Gene in Breast Cancer Patients Treated With Breast-Conserving Surgery and Whole-Breast Irradiation (BCS + RT)
Published in International journal of radiation oncology, biology, physics (01-06-2011)“…Purpose TP53BP1 is a key component of radiation-induced deoxyribonucleic acid damage repair. The purpose of this study was to evaluate the significance of a…”
Get full text
Journal Article -
7
Evaluation of Diabetic Patients with Breast Cancer Treated with Metformin during Adjuvant Radiotherapy
Published in International Journal of Breast Cancer (01-01-2013)“…Purpose. The purpose of this study was to evaluate acute locoregional toxicity in patients with breast cancer receiving concurrent metformin plus radiation…”
Get full text
Journal Article -
8
Abstract P5-05-07: Foxo3a activation contributes to the synergy of imipridone and radiation in triple-negative breast cancer
Published in Cancer research (Chicago, Ill.) (15-02-2020)“…Abstract Purpose/Objective: Imipridone (IMIP) is a small molecule DRD2 antagonist that has shown efficacy in preclinical and early phase clinical studies in…”
Get full text
Journal Article -
9
The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo
Published in Oncotarget (19-04-2019)“…High-grade gliomas are lethal malignancies that cause morbidity and mortality due to local progression rather than metastatic spread. Our group has previously…”
Get full text
Journal Article -
10
VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells
Published in Oncotarget (25-05-2018)“…DNA double-strand breaks (DSBs) can be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR). We demonstrate the selectivity of…”
Get full text
Journal Article -
11
Radiation Therapy and Talimogene Laherparepvec (TVEC) Synergize in the Treatment of Melanoma
Published in The Journal of immunology (1950) (01-05-2017)“…Abstract Talimogene laherparepvec (TVEC), an oncolytic virus, is an FDA-approved therapy that increases the overall survival of locally advanced and metastatic…”
Get full text
Journal Article -
12
Abstract 2765: Combination ONC201 and radiation therapy in the treatment of breast cancer
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Purpose: Metastatic breast cancer patients continue to have poor outcomes on current treatments, and thus, novel therapies in combination with…”
Get full text
Journal Article -
13
Riluzole Enhances Ionizing Radiation-Induced Cytotoxicity in Human Melanoma Cells that Ectopically Express Metabotropic Glutamate Receptor 1 In Vitro and In Vivo
Published in Clinical cancer research (01-04-2011)“…Brain metastases are a common preterminal event in patients with metastatic melanoma and require radiation therapy. Our group has previously shown that human…”
Get full text
Journal Article -
14
Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells
Published in Pigment cell and melanoma research (01-03-2014)“…Summary Gain of function of the neuronal receptor, metabotropic glutamate receptor 1 (Grm1), was sufficient to induce melanocytic transformation in vitro and…”
Get full text
Journal Article -
15
Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy
Published in Breast cancer research and treatment (01-04-2011)“…The mediator of DNA damage checkpoint protein 1 (MDC1) regulates cell cycle checkpoints and recruits repair proteins to sites of double-stranded DNA damage…”
Get full text
Journal Article -
16
Low p53 Binding Protein 1 (53BP1) Expression Is Associated With Increased Local Recurrence in Breast Cancer Patients Treated With Breast-Conserving Surgery and Radiotherapy
Published in International journal of radiation oncology, biology, physics (01-08-2012)“…Purpose To investigate whether the expression of p53 binding protein 1 (53BP1) has prognostic significance in a cohort of early-stage breast cancer patients…”
Get full text
Journal Article -
17
Abstract 2489: Targeting pro-survival BCL-2 family members increases radiation sensitivity in breast cancer cells
Published in Cancer research (Chicago, Ill.) (15-04-2011)“…Abstract In previous studies we have shown that BCL-2 expression was associated with an increased risk of local recurrence in patients with early stage breast…”
Get full text
Journal Article -
18
Disruption of GRM 1‐mediated signalling using riluzole results in DNA damage in melanoma cells
Published in Pigment cell and melanoma research (01-03-2014)“…Summary Gain of function of the neuronal receptor, metabotropic glutamate receptor 1 ( G rm1), was sufficient to induce melanocytic transformation in vitro and…”
Get full text
Journal Article -
19
CD8+, Radiosensitive T Cells of Parental Origin, Oppose Cells Capable of Down-Regulating Cytotoxicity in Murine Acute Lethal Graft-versus-Host Disease
Published in Clinical immunology and immunopathology (01-12-1998)“…Murine graft-versus-host (GVH) disease takes two forms depending upon the parental/F1 strain combination employed. Anemia, lymphopenia, hypogammaglobulinemia,…”
Get full text
Journal Article